{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:11:27Z","timestamp":1788545487990,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101034420"],"award-info":[{"award-number":["101034420"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["18142"],"award-info":[{"award-number":["18142"]}],"id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-003519"],"award-info":[{"award-number":["INV-003519"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cmi.2025.07.033","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T15:55:45Z","timestamp":1754495745000},"page":"1972-1979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections"],"prefix":"10.1016","volume":"31","author":[{"given":"Nasreen","family":"Hassoun-Kheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam Roncal","family":"Redin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Appiah-Korang","family":"Labi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Stewardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mical","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen B.","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Sharland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlieke E.A.","family":"de Kraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.07.033_bib1","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.cmi.2023.09.001","article-title":"A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe","volume":"30","author":"Hassoun-Kheir","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib2","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.cmi.2023.12.013","article-title":"Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis","volume":"30","author":"Kingston","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib3","doi-asserted-by":"crossref","first-page":"106184","DOI":"10.1016\/j.ijantimicag.2020.106184","article-title":"Systematic review of the impact of appropriate versus inappropriate initial antibiotic therapy on outcomes of patients with severe bacterial infections","volume":"56","author":"Bassetti","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2025.07.033_bib4","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1128\/AAC.00627-10","article-title":"Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis","volume":"54","author":"Paul","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.033_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/epirev\/mxab001","article-title":"Burden of antimicrobial resistance: Compared to what?","volume":"43","author":"de Kraker","year":"2022","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.cmi.2025.07.033_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1086\/510075","article-title":"Does antibiotic selection impact patient outcome?","volume":"44","author":"Harbarth","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.033_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13756-020-00796-5","article-title":"Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections","volume":"9","author":"Zhang","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2025.07.033_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225478","article-title":"Appropriate empirical antibiotic therapy and mortality: Conflicting data explained by residual confounding","volume":"14","author":"Schuttevaer","year":"2019","journal-title":"PLOS One"},{"key":"10.1016\/j.cmi.2025.07.033_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/jech-2022-219267","article-title":"Causal inference and effect estimation using observational data","volume":"76","author":"Igelstr\u00f6m","year":"2022","journal-title":"J Epidemiol Commun Health"},{"key":"10.1016\/j.cmi.2025.07.033_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/EDE.0b013e31818ef366","article-title":"The consistency statement in causal inference: a definition or an assumption?","volume":"20","author":"Cole","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.cmi.2025.07.033_bib11","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/EDE.0000000000000823","article-title":"On Well-defined hypothetical interventions in the potential outcomes framework","volume":"29","author":"VanderWeele","year":"2018","journal-title":"Epidemiology"},{"key":"10.1016\/j.cmi.2025.07.033_bib12","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1093\/cid\/ciaa136","article-title":"Estimating the effect of healthcare-associated infections on excess length of hospital stay using inverse probability-weighted survival curves","volume":"71","author":"Pouwels","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.033_bib13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jss.2025.03.043","article-title":"Associations in medical research can be misleading: a clinician\u2019s guide to causal inference","volume":"310","author":"Karamitros","year":"2025","journal-title":"J Surg Res"},{"key":"10.1016\/j.cmi.2025.07.033_bib14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/oxfordjournals.aje.a009758","article-title":"Confounding by indication: an example of variation in the use of epidemiologic terminology","volume":"149","author":"Salas","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2025.07.033_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajog.2017.04.016","article-title":"Confounding, causality, and confusion: The role of intermediate variables in interpreting observational studies in obstetrics","volume":"217","author":"Ananth","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cmi.2025.07.033_bib16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/aje\/kwad213","article-title":"Selection bias requires selection: The case of collider stratification bias","volume":"193","author":"Lu","year":"2024","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cmi.2025.07.033_bib17","first-page":"107","article-title":"Collider bias in observational studies","volume":"119","author":"T\u00f6nnies","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.cmi.2025.07.033_bib18","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: Example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2025.07.033_bib19","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jama.2020.9151","article-title":"Immortal time bias in observational studies","volume":"325","author":"Yadav","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2025.07.033_bib20","series-title":"Nomenclature, definitions and methodological approaches to determine the impact of antimicrobial therapy on drug-resistant bloodstream infections PROSPERO International prospective register of systematic reviews","author":"Hassoun-Kheir","year":"2022"},{"key":"10.1016\/j.cmi.2025.07.033_bib21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: A comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cmi.2025.07.033_bib22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.cmi.2021.01.004","article-title":"Methodological quality of studies evaluating the burden of drug-resistant infections in humans due to the WHO Global Antimicrobial Resistance Surveillance System target bacteria","volume":"27","author":"Pezzani","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib23","unstructured":"Covidence. Covidence systematic review software. Melbourne: Veritas Health Innovation Melbourne. Available from: https:\/\/www.covidence.org"},{"key":"10.1016\/j.cmi.2025.07.033_bib24","series-title":"Critical appraisal tools","author":"JBI","year":"2018"},{"key":"10.1016\/j.cmi.2025.07.033_bib25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0885066616677710","article-title":"Risk of mortality of catheter-related bloodstream infections caused by acinetobacter species: Is early removal of the catheters associated with a better survival outcome?","volume":"33","author":"Lee","year":"2018","journal-title":"J Inten Care Med"},{"key":"10.1016\/j.cmi.2025.07.033_bib26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1086\/591453","article-title":"Controlling for severity of illness in outcome studies involving infectious diseases: Impact of measurement at different time points","volume":"29","author":"Thom","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2025.07.033_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1128\/AAC.00901-06","article-title":"Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia","volume":"51","author":"Osih","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.033_bib28","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1017\/ice.2021.216","article-title":"Attributable mortality of vancomycin resistance in ampicillin-resistant Enterococcus faecium bacteremia in Denmark and the Netherlands: A matched cohort study","volume":"43","author":"Rottier","year":"2022","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2025.07.033_bib29","doi-asserted-by":"crossref","first-page":"O1028","DOI":"10.1111\/1469-0691.12716","article-title":"A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia","volume":"20","author":"Nutman","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011432","article-title":"Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: A retrospective cohort study","volume":"5","author":"Schweizer","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2025.07.033_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13756-019-0520-8","article-title":"A retrospective analysis of Pseudomonas aeruginosa bloodstream infections: Prevalence, risk factors, and outcome in carbapenem-susceptible and -non-susceptible infections","volume":"8","author":"Shi","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.cmi.2025.07.033_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cmi.2015.10.034","article-title":"Gram-negative bacteraemia: A multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals","volume":"22","author":"Fitzpatrick","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12941-016-0122-8","article-title":"Mortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study","volume":"15","author":"Yilmaz","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.cmi.2025.07.033_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/antibiotics12020405","article-title":"Carbapenem-resistant enterobacteriaceae (CRE) among children with cancer: Predictors of mortality and treatment outcome","volume":"12","author":"Madney","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.cmi.2025.07.033_bib35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jgar.2024.06.010","article-title":"Risk factors for mortality in Acinetobacter baumannii bloodstream infections and development of a predictive mortality model","volume":"38","author":"Corcione","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.cmi.2025.07.033_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297161","article-title":"Carbapenem-resistant Klebsiella pneumoniae bloodstream infections in haematological malignances and hematopoietic stem cell transplantation: Clinical impact of combination therapy in a 10-year Brazilian cohort","volume":"19","author":"de Souza","year":"2024","journal-title":"PLOS One"},{"key":"10.1016\/j.cmi.2025.07.033_bib37","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3947\/ic.2022.0096","article-title":"Impact of inappropriate empirical antibiotic on outcomes in community-acquired third generation cephalosporin resistant enterobacterales bacteremia","volume":"54","author":"Nasomsong","year":"2022","journal-title":"Infect Chemother"},{"key":"10.1016\/j.cmi.2025.07.033_bib38","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cmi.2015.05.013","article-title":"Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization","volume":"21","author":"Brigmon","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1471-2334-8-116","article-title":"Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: A cohort study","volume":"8","author":"Thom","year":"2008","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2025.07.033_bib40","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1128\/AAC.00063-08","article-title":"Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: Risk factors for inadequate initial antimicrobial therapy","volume":"52","author":"Tumbarello","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2025.07.033_bib41","doi-asserted-by":"crossref","first-page":"869822","DOI":"10.3389\/fmed.2022.869822","article-title":"Effects of inappropriate administration of empirical antibiotics on mortality in adults with bacteraemia: Systematic review and meta-analysis","volume":"9","author":"Hung","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.cmi.2025.07.033_bib42","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cmi.2023.12.030","article-title":"Universal Risk Factors for Mortality in Bloodstream Infections (UNIFORM): A systematic review and Delphi survey","volume":"30","author":"Varon","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jhin.2021.02.026","article-title":"Impact of healthcare-associated infection on length of stay","volume":"114","author":"Stewart","year":"2021","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.cmi.2025.07.033_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40471-016-0069-5","article-title":"The consistency assumption for causal inference in social epidemiology: When a rose is not a rose","volume":"3","author":"Rehkopf","year":"2016","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.cmi.2025.07.033_bib45","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.2022.21383","article-title":"Target trial emulation: A framework for causal inference from observational data","volume":"328","author":"Hern\u00e1n","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2025.07.033_bib46","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10654-022-00929-7","article-title":"Emulation of a target trial with sustained treatment strategies: An application to prostate cancer using both inverse probability weighting and the g-formula","volume":"37","author":"Smith","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cmi.2025.07.033_bib47","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/aje\/kwab158","article-title":"Effect of delays in concordant antibiotic treatment on mortality in patients with hospital-acquired acinetobacter species bacteremia: Emulating a target randomized trial with a 13-year retrospective cohort","volume":"190","author":"Lim","year":"2021","journal-title":"Am J Epidemiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2500374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2500374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:27:10Z","timestamp":1772882830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2500374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1198743X2500374X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.07.033","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nomenclature, definitions, and methodological approaches to estimate the association between antimicrobial treatment and clinical outcomes of drug-resistant bloodstream infections","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}